REMINDER: Analysis of Amgen v. Sandoz Federal Circuit Decision Webinar

Amgen v. Sandoz (filgrastim)

Please join us on August 12, 2015 at 12:30 pm EDT for a lively discussion about the Amgen v. Sandoz Federal Circuit decision as Goodwin Procter partners Elaine Herrmann Blais and Robert Cerwinski analyze the outcome and discuss what is likely to happen next, along with how the decision impacts biosimilars strategy going forward.

To register for the webinar, please click here.

Download PDF

Tagged with 

Comments are closed.